{
    "lastUpdated": "2025-04-16 08:00:00",
    "nextUpdate": "2025-04-17 08:00:00",
    "counts": {
        "academic": 5,
        "clinical": 3,
        "policy": 2
    },
    "latest": {
        "academic": [
            {
                "date": "2025-04-15",
                "title": "干细胞治疗在神经退行性疾病中的最新进展",
                "source": "Nature",
                "link": "https://www.nature.com/articles/example"
            },
            {
                "date": "2025-04-14",
                "title": "CAR-T细胞疗法在实体瘤治疗中的突破",
                "source": "Science",
                "link": "https://www.science.org/articles/example"
            }
        ],
        "clinical": [
            {
                "date": "2025-04-16",
                "title": "新型CAR-NK细胞疗法进入II期临床试验",
                "trialId": "NCT0123456789",
                "link": "https://clinicaltrials.gov/study/NCT0123456789"
            },
            {
                "date": "2025-04-13",
                "title": "干细胞治疗帕金森病III期临床试验结果公布",
                "trialId": "NCT9876543210",
                "link": "https://clinicaltrials.gov/study/NCT9876543210"
            }
        ],
        "policy": [
            {
                "date": "2025-04-12",
                "title": "国家药监局发布细胞治疗产品注册技术指导原则",
                "agency": "国家药监局",
                "link": "https://www.nmpa.gov.cn/example"
            },
            {
                "date": "2025-04-10",
                "title": "FDA更新干细胞治疗监管框架",
                "agency": "FDA",
                "link": "https://www.fda.gov/example"
            }
        ]
    }
}
